Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.01
Delayed Data
As of 1:09pm ET
 -0.84 / -1.50%
Today’s Change
46.17
Today|||52-Week Range
60.34
-5.29%
Year-to-Date

Today’s Trading

Previous close55.85
Today’s open55.25
Day’s range54.60 - 55.47
Volume514,339
Average volume (3 months)1,433,669
Market cap$109.5B
Dividend yield1.74%
Data as of 1:09pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.65%
Revenue growth (last year)+1.43%
P/E ratio4.1
Price/Sales9.38
Price/Book20.81

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.19+0.46%
GSKGlaxoSmithKline+0.07+0.16%
ABBVAbbVie+0.21+0.34%
BMYBristol-Myers Squibb-0.65-0.90%
Data as of 12:23pm ET, 05/03/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)$0.58
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Partner Offers

Search for Jobs